Navigation Links
Genomenon Accelerates Rare and Genetic Disease Research with Mastermind v2.0
Date:11/6/2019

Genomenon® announced the release of Mastermind® version 2.0 today. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases.

Patients, particularly those with rare diseases, don’t always have a name for their condition. This makes it very difficult to diagnose and treat their disease. The ability to search the genetic literature by symptoms (following the Human Phenotype Ontology, or HPO) helps clinicians narrow their diagnosis to the appropriate disease and treatment.

Genomenon’s Mastermind Genomic Search Engine is the world’s largest and most complete source of genomic evidence. Doctors and researchers use Mastermind to find the scientific evidence relevant to their patients’ DNA profile for diagnostic and therapeutic recommendations. The new release of Mastermind includes a more streamlined search function to help doctors more quickly scour through the millions of research articles to find cases that match their patients’ genomic profile and symptoms.

The ability to search by phenotype was the top feature requested by the children’s hospitals and genetic testing labs that use Mastermind for variant interpretation. A preview of the new version was well received at the American Society for Human Genetics annual meeting in October.

"We are world-renowned for the speed of our WGS (whole genome sequencing) interpretations, and using Mastermind has been a crucial step in accelerating our progress." said Shareef Nahas, Senior Director of Clinical Operations for Rady Children's Institute for Genomic Medicine. "This new functionality will be invaluable in our ongoing work to diagnose and treat babies with rare diseases."

“The ability to search by phenotype gives Mastermind users even more power to discover which genes in a patient’s DNA are most likely to be relevant based on empirical data in the medical literature.” Said Dr. Mark Kiel, co-founder and Chief Science Officer of Genomenon.

About Genomenon

Genomenon connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases. Our flagship product, the Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield and assure repeatability in reporting genetic testing results. We license our Mastermind Curated Genomic Datasets to pharmaceutical and bio-pharma companies to inform precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.

For more information, visit Genomenon.com.

Read the full story at https://www.prweb.com/releases/genomenon_accelerates_rare_and_genetic_disease_research_with_mastermind_v2_0/prweb16701259.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. The China National Genebank accelerates growth by a strategic alliance with BioStorage Technologies
2. Fragmented sleep accelerates cancer growth
3. Study finds climate change accelerates hybridization between native, invasive trout
4. Genetic circuit allows both individual freedom, collective good
5. Epigenetic changes shed light on biological mechanism of autism
6. Europe needs genetically engineered crops, scientists say
7. Genetics Society of Americas GENETICS journal highlights for May 2013
8. Study examines effects of genetic variants for infants with neonatal abstinence syndrome
9. Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
10. Fred Hutch evolutionary geneticist Harmit Malik selected as an HHMI investigator
11. Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... November 06, 2019 , ... Genomenon® ... Search Engine now includes the ability to search the entirety of the genomic ... with genetic and rare diseases. , Patients, particularly those with rare diseases, don’t ...
(Date:11/2/2019)... ... November 01, 2019 , ... Stay on top of current ... device industries. Access to all webinars is free, so be sure to register today ... , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , ...
(Date:10/30/2019)... ... October 30, 2019 , ... Amberdata Inc., the ... firms, including Fenbushi Capital, DF Capital, Rising Tide Fund, and HWVP. The ... to further accelerate its position as the leading data provider of institutional-grade blockchain ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... ... German Shepherd, was demonstrating signs of osteoarthritis in April 2019. He was lame and ... willingness to play were normal, it was clear that he was in pain. , Ole’s ... and Referral Center in San Diego, California. Dr. Mullen is an experienced VetStem ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of Health Sciences ... technology play in educating the next generation of health care providers. , The ... by WesternU administrators and representatives of companies working with the University on a ...
(Date:10/22/2019)... (PRWEB) , ... October 22, 2019 , ... nQ Medical, ... Business School’s 2019 Most Fundable Companies List which was announced at a showcase event ... $10 million in annual revenue, strong business plans, and impressive near-term growth projections to ...
(Date:10/17/2019)... NEW HAVEN, Conn. (PRWEB) , ... October 16, ... ... health company that provides personalized, easy-to-understand, web-based genetic counseling information, has published a ... over a five year period and provides guidance as to how patients and ...
Breaking Biology Technology: